Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter In the Matter of Sanofi/Maze Therapeutics
Date
Matter Number
D09422
By
Lina M. Khan, Chair;
Rebecca Kelly Slaughter, Commissioner
File
Text of Statement
(126.92 KB)